Proof of concept study designed to evaluate the effects of Octreolin on hepatic venous pressure gradient in patients with cirrhosis and portal hypertension [Estudio de prueba de concepto diseñado para evaluar los efectos de Octreolin sobre el gradiente de presión venosa hepática en sujetos con cirrosis e hipertensión portal]

Trial Profile

Proof of concept study designed to evaluate the effects of Octreolin on hepatic venous pressure gradient in patients with cirrhosis and portal hypertension [Estudio de prueba de concepto diseñado para evaluar los efectos de Octreolin sobre el gradiente de presión venosa hepática en sujetos con cirrosis e hipertensión portal]

Recruiting
Phase of Trial: Phase II

Latest Information Update: 03 Nov 2014

At a glance

  • Drugs Octreotide (Primary)
  • Indications Liver cirrhosis; Portal hypertension
  • Focus Pharmacokinetics; Therapeutic Use
  • Sponsors Chiasma
  • Most Recent Events

    • 03 Nov 2014 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top